Shaik Barak Tulla Joins Sun Pharma to Supercharge Commercial Strategy

Sun Pharma has welcomed Shaik Barak Tulla as its new Senior Vice President, signaling a bold step in the company's journey toward enhanced commercial excellence and global growth. With over 25 years of leadership in the pharmaceutical space, Shaik brings a proven track record of transforming business units and building high-performing teams. At Cipla, where he most recently served as SVP and Chief Commercial Head – Acute Cluster, he played a pivotal role in growing market share and profitability across critical therapy areas including respiratory, anti-infectives, and critical care.

Shaik is widely recognized for his strategic foresight, digital-first approach, and strong people leadership. His success in launching and elevating brands like Foracort and Azee and championing initiatives such as Berok Zindagi, has earned him a reputation as a forward-thinking leader. Armed with credentials from premier institutes like ISB, INSEAD, and IIM Ahmedabad, he now steps into Sun Pharma with a clear mission: to shape the company’s commercial strategy and scale innovation in a fast-evolving global healthcare market.